Balance Sheet for Intra-Cellular Therapies Inc. (ITCI)

$ 19.04   0.11 (+0.58%) Volume: 352.04k 2:34 PM EDT Aug 12, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 107,637 54,948 37,790 48,642 47,159
Restrictable Cash - - - - -
Marketable Securities 116,373 292,583 426,541 335,458 428,041
Accounts Receivable - - - 94 31
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - 94 31
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 6,314 7,908 4,884 4,005 8,025
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 230,324 355,439 469,215 388,200 483,256
Land and Improvements - - - - -
Buildings and Improvement 1,240 149 - - -
Machinery, Furniture and Equipment 4,528 4,044 3,830 3,176 3,132
Construction in Progress - - - - -
Fixed Assets, Other 18,252 - - - -
Fixed Assets, Total 24,020 4,194 3,830 3,176 3,132
Gross Fixed Assets 24,020 4,194 3,830 3,176 3,132
Accumulated Depreciation (3,508) (3,034) (2,693) (2,549) (2,357)
Net Fixed Assets 20,512 1,160 1,137 628 776
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes 265 529 1,058 - -
Other Non-Current Assets 86 79 76 76 72
Total Non-Current Assets 20,863 1,768 2,271 703 847
Total Assets 251,186 357,206 471,487 388,904 484,104
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 7,425 13,961 6,174 3,755 1,633
Short Term Debt 3,187 - - 125,000 -
Notes Payable - - - - -
Accrued Expenses 16,139 20,045 6,424 5,329 3,423
Accrued Liabilities 16,139 20,045 6,424 5,329 3,423
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 9,473 2,293 1,612 (123,552) 1,207
Total Current Liabilities 36,224 36,299 14,210 10,532 6,264
Long Term Debt N/A N/A N/A - -
Deferred Income Tax - 3,192 2,840 2,869 1,597
Other Non-Current Liabilities - 3,192 2,840 2,869 1,597
Minority Interest - - - - -
Capital Lease Obligations 19,955 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 19,955 3,192 2,840 2,869 1,597
Total Liabilities 56,179 39,492 17,050 13,401 7,861
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 195,007 317,715 454,437 375,503 476,243
Common Par 6 5 5 4 4
Additional Paid in Capital 904,972 880,753 862,480 685,291 669,878
Cumulative Translation Adjustments - - - - -
Retained Earnings (710,098) (562,376) (407,249) (309,475) (193,049)
Treasury Stock - - - - -
Other Equity Adjustments 128 (668) (799) (317) (590)
Total Capitalization 195,007 317,715 454,437 375,503 476,243
Total Equity 195,007 317,715 454,437 375,503 476,243
Total Liabilities & Shareholder's Equity 251,186 357,206 471,487 388,904 484,104
Cash Flow (147,068) (154,553) (98,417) (117,167) (105,645)
Working Capital 194,100 319,140 455,006 377,668 476,993
Free Cash Flow (128,684) (118,560) (81,215) (91,306) (103,141)
Invested Capital 195,007 317,715 454,437 375,503 476,243
Shares Outstanding - Common Class Only 55,507 54,895 54,598 43,293 43,156
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 55,507 54,895 54,598 43,293 43,156
Total Common Shares Outstanding 55,507 54,895 54,598 43,293 43,156
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 55,186 54,708 46,182 43,240 36,069
Diluted Weighted Shares Outstanding 55,186 54,708 46,182 43,240 36,069